Twist Bioscience Corp (TWST)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Twist Bioscience Corp-Aktie (TWST)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.52% 96.06	92.79	88.71	84.71	81.46
Cost Of Revenue	4.29% 44.76	46.77	45.87	46.48	46.19
Gross Profit	11.45% 51.30	46.03	42.84	38.23	35.27
Operating Expenses	7.05% 81.42	87.59	77.48	74.28	124.19
Benefits Costs and Expenses	42.80% 75.48	131.95	120.21	119.46	166.84
Costs And Expenses	6.09% 126.18	134.35	123.36	120.75	170.39
Operating Income/Loss	27.53% -30.12	-41.56	-34.64	-36.04	-88.92
Income/Loss From Continuing Operations Before Tax	152.57% 20.58	-39.15	-31.50	-34.75	-85.38
Income Tax Expense/Benefit	9.14% 0.191	0.175	0.097	-0.096	0.191
Income/Loss From Continuing Operations After Tax	151.85% 20.39	-39.33	-31.59	-34.66	-85.57
Net Income/Loss	151.85% 20.39	-39.33	-31.59	-34.66	-85.57
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.58% 59.99	59.65	59.16	0.21	58.15
Diluted Average Shares	2.54% 61.16	59.65	59.16	0.21	58.15
Basic Earnings Per Share	151.52% 0.34	-0.66	-0.53	-0.59	-1.47
Diluted Earnings Per Share	150.00% 0.33	-0.66	-0.53	-0.59	-1.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

WAT

$296.48

1.76%

DGX

$178.70

1.62%

$273.78

1.51%

NTRA

$169.34

0.65%

MTD

$1,276.00

1.92%

IQV

$183.74

3.71%